Refractory Waldenstrom's Macroglobulinaemia

Also known as: Waldenstrom's macroglobulinaemia refractory / Refractory Waldenström macroglobulinemia / Refractory Lymphoplasmacytic Lymphoma / Refractory Waldenstrom's Macroglobulinemia / Refractory Waldenstrom Macroglobulinemia / Waldenstrom's Macroglobulinemia Refractory

DrugDrug NameDrug Description
DB01590EverolimusA mammalian target of rapamycin (mTOR) kinase inhibitor used to treat various types of malignancies.
DrugDrug NamePhaseStatusCount
DB00928Azacitidine1Active Not Recruiting1
DB09053Ibrutinib1Active Not Recruiting2
DB09053Ibrutinib1Completed1
DB00480Lenalidomide1Active Not Recruiting2
DB00480Lenalidomide1Withdrawn1
DB08935Obinutuzumab1Active Not Recruiting1
DB09037Pembrolizumab1Completed1
DB11759Pevonedistat1Active Not Recruiting1
DB08910Pomalidomide1Active Not Recruiting1
DB11850Ublituximab1Withdrawn1
DB14989Umbralisib1Withdrawn1
DB00531Cyclophosphamide1 / 2Recruiting1
DB01073Fludarabine1 / 2Recruiting1
DB00480Lenalidomide1 / 2Active Not Recruiting1
DB06132Nivolumab1 / 2Active Not Recruiting1
DB09035Nivolumab1 / 2Active Not Recruiting1
DB08889Carfilzomib2Terminated1
DB00531Cyclophosphamide2Completed1
DB00091Cyclosporine2Completed1
DB09331Daratumumab2Terminated1
DB01073Fludarabine2Completed1
DB09053Ibrutinib2Active Not Recruiting1
DB09053Ibrutinib2Completed1
DB09053Ibrutinib2Terminated1
DB09054Idelalisib2Completed1
DB09570Ixazomib2Active Not Recruiting1
DB00688Mycophenolate mofetil2Completed1
DB09037Pembrolizumab2Completed1
DB00073Rituximab2Terminated1
DB17366MB-102 CD123 CARNot AvailableEnrolling by Invitation1
DB11581VenetoclaxNot AvailableRecruiting1